Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Orthogon Therapeutics is a biotechnology company specializing in the development of first-in-class antiviral small molecule drugs using biophysics- and structure-based drug design. Their primary focus is on creating orally administrable treatments targeting polyomaviruses, particularly the BK virus, which poses significant risks to immunocompromised patients, especially transplant recipients. Orthogon has developed small molec...
Orthogon Therapeutics is a biotechnology company specializing in the development of first-in-class antiviral small molecule drugs using biophysics- and structure-based drug design. Their primary focus is on creating orally administrable treatments targeting polyomaviruses, particularly the BK virus, which poses significant risks to immunocompromised patients, especially transplant recipients. Orthogon has developed small molecule drugs that directly target viral proteins essential to the polyomavirus life cycle.

List your booth number for exhibitions, ask us